Cargando…

Micropuncture closure following high density microarray patch application in healthy subjects

BACKGROUND: The high‐density microarray patch (HD‐MAP) promises to be a robust vaccination platform with clear advantages for future global societal demands for health care management. The method of action has its base not only in efficient delivery of vaccine but also in the reliable induction of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Henricson, Joakim, Muller, David A., Baker, S. Ben, Iredahl, Fredrik, Togö, Totte, Anderson, Chris D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907643/
https://www.ncbi.nlm.nih.gov/pubmed/35064694
http://dx.doi.org/10.1111/srt.13131
_version_ 1784884212760838144
author Henricson, Joakim
Muller, David A.
Baker, S. Ben
Iredahl, Fredrik
Togö, Totte
Anderson, Chris D.
author_facet Henricson, Joakim
Muller, David A.
Baker, S. Ben
Iredahl, Fredrik
Togö, Totte
Anderson, Chris D.
author_sort Henricson, Joakim
collection PubMed
description BACKGROUND: The high‐density microarray patch (HD‐MAP) promises to be a robust vaccination platform with clear advantages for future global societal demands for health care management. The method of action has its base not only in efficient delivery of vaccine but also in the reliable induction of a local innate physical inflammatory response to adjuvant the vaccination process. The application process needs to induce levels of reactivity, which are acceptable to the vaccine, and from which the skin promptly recovers. MATERIALS AND METHODS: 1 × 1 cm HD‐MAP patches containing 5000, 250‐μm long microprojections were applied to the skin in 12 healthy volunteers. The return of skin barrier function was assessed by transepidermal water loss (TEWL) and reaction to topical histamine challenge. RESULTS: Skin barrier recovery by 48 h was confirmed for all HD‐MAP sites by recovered resistance to the effects of topical histamine application. CONCLUSIONS: Our previous observation, that the barrier disruption indicator TEWL returns to normal by 48 h, is supported by this paper's demonstration of return of skin resistance to topical histamine challenge in twelve healthy subjects.
format Online
Article
Text
id pubmed-9907643
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-99076432023-04-13 Micropuncture closure following high density microarray patch application in healthy subjects Henricson, Joakim Muller, David A. Baker, S. Ben Iredahl, Fredrik Togö, Totte Anderson, Chris D. Skin Res Technol Original Articles BACKGROUND: The high‐density microarray patch (HD‐MAP) promises to be a robust vaccination platform with clear advantages for future global societal demands for health care management. The method of action has its base not only in efficient delivery of vaccine but also in the reliable induction of a local innate physical inflammatory response to adjuvant the vaccination process. The application process needs to induce levels of reactivity, which are acceptable to the vaccine, and from which the skin promptly recovers. MATERIALS AND METHODS: 1 × 1 cm HD‐MAP patches containing 5000, 250‐μm long microprojections were applied to the skin in 12 healthy volunteers. The return of skin barrier function was assessed by transepidermal water loss (TEWL) and reaction to topical histamine challenge. RESULTS: Skin barrier recovery by 48 h was confirmed for all HD‐MAP sites by recovered resistance to the effects of topical histamine application. CONCLUSIONS: Our previous observation, that the barrier disruption indicator TEWL returns to normal by 48 h, is supported by this paper's demonstration of return of skin resistance to topical histamine challenge in twelve healthy subjects. John Wiley and Sons Inc. 2022-01-22 /pmc/articles/PMC9907643/ /pubmed/35064694 http://dx.doi.org/10.1111/srt.13131 Text en © 2022 The Authors. Skin Research and Technology published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Henricson, Joakim
Muller, David A.
Baker, S. Ben
Iredahl, Fredrik
Togö, Totte
Anderson, Chris D.
Micropuncture closure following high density microarray patch application in healthy subjects
title Micropuncture closure following high density microarray patch application in healthy subjects
title_full Micropuncture closure following high density microarray patch application in healthy subjects
title_fullStr Micropuncture closure following high density microarray patch application in healthy subjects
title_full_unstemmed Micropuncture closure following high density microarray patch application in healthy subjects
title_short Micropuncture closure following high density microarray patch application in healthy subjects
title_sort micropuncture closure following high density microarray patch application in healthy subjects
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907643/
https://www.ncbi.nlm.nih.gov/pubmed/35064694
http://dx.doi.org/10.1111/srt.13131
work_keys_str_mv AT henricsonjoakim micropunctureclosurefollowinghighdensitymicroarraypatchapplicationinhealthysubjects
AT mullerdavida micropunctureclosurefollowinghighdensitymicroarraypatchapplicationinhealthysubjects
AT bakersben micropunctureclosurefollowinghighdensitymicroarraypatchapplicationinhealthysubjects
AT iredahlfredrik micropunctureclosurefollowinghighdensitymicroarraypatchapplicationinhealthysubjects
AT togototte micropunctureclosurefollowinghighdensitymicroarraypatchapplicationinhealthysubjects
AT andersonchrisd micropunctureclosurefollowinghighdensitymicroarraypatchapplicationinhealthysubjects